Drs. Alpheus Bingham (CDD BOD member) and Barry Bunin (CDD CEO & BOD member) will present back-to-back at the World Pharma Innovation Congress hosted by Terrapin at the Hilton Financial District in San Francisco (Feb 1).
Dr. Alpheus Bingham, Founder and Member, Board of Directors at Innocentive, and a member of CDD’s board of directions, will present on “Tapping the long tail knowledge of the crowd” (at 2:30PM), followed by Dr. Bunin’s presentation titled “The biopharma facebook: social networking for science” on protecting IP while advancing shared knowledge (at 2:50PM).
Both will participate on the panel at 4:40PM (also on Feb 1) to discuss the emerging interdependency between competitive and pre-competitive knowledge in drug discovery:
- Dr. Tim Willson, Director of Chemical Biology, GlaxoSmithKline
- Dr. Tariq Ghayur, Senior Principal Scientist, Abbott Laboratories
- Dr. Alpheus Bingham, Founder and Member, Board of Directors, Innocentive
- Dr. Barry Bunin, Chief Executive Officer, Collaborative Drug Discovery
The panel should be quite provocative, given the timely topics:
- Defining what work should be considered pre-competitive
- Protecting research for open access to expedite drug discovery
- Establishing the academic-pharma partnership for innovation
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities!
CDD Vault: Drug Discovery Informatics your whole project team will embrace!